Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology

Despite considerable research to uncover them, the anatomic and neuropathologic correlates of memory impairment in dementia with Lewy bodies (DLB) remain unclear. While some studies have implicated Lewy bodies in the neocortex, others have pointed to α-synuclein pathology in the hippocampus. We systematically examined hippocampal Lewy pathology and its distribution in hippocampal subfields in 95 clinically and neuropathologically characterized human cases of DLB, finding that α-synuclein pathology was highest in two hippocampal-related subregions: the CA2 subfield and the entorhinal cortex (EC). While the EC had numerous classic somatic Lewy bodies, CA2 contained mainly Lewy neurites in presumed axon terminals, suggesting the involvement of the EC → CA2 circuitry in the pathogenesis of DLB symptoms. Clinicopathological correlations with measures of verbal and visual memory supported a role for EC Lewy pathology, but not CA2, in causing these memory deficits. Lewy pathology in CA1—the main output region for CA2—correlated best with results from memory testing despite a milder pathology. This result indicates that CA1 may be more functionally relevant than CA2 in the context of memory impairment in DLB. These correlations remained significant after controlling for several factors, including concurrent Alzheimer's pathology (neuritic plaques and neurofibrillary tangles) and the interval between time of testing and time of death. Our data suggest that although hippocampal Lewy pathology in DLB is predominant in CA2 and EC, memory performance correlates most strongly with CA1 burden. SIGNIFICANCE STATEMENT This study provides a detailed neuropathologic analysis of hippocampal Lewy pathology in human patients with autopsy-confirmed dementia with Lewy bodies. The approach—informed by regional molecular markers, concurrent Alzheimer's pathology analysis, and relevant clinical data—helps tease out the relative contribution of Lewy pathology to memory dysfunction in the disease. Levels of Lewy pathology were found to be highest in the hippocampal CA2 subregion and entorhinal cortex, implicating a potentially overlooked circuit in disease pathogenesis. However, correlation with memory performance was strongest with CA1. This unexpected finding suggests that Lewy pathology must reach a critical burden across hippocampal circuitry to contribute to memory dysfunction beyond that related to other factors, notably coexisting Alzheimer's disease tau pathology.

[1]  A. Martínez-Marcos,et al.  Hippocampal α‐synuclein and interneurons in Parkinson's disease: Data from human and mouse models , 2016, Movement disorders : official journal of the Movement Disorder Society.

[2]  M. Onofrj,et al.  Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease , 2016, Neurobiology of Aging.

[3]  Guy B. Williams,et al.  Differential Atrophy of Hippocampal Subfields: A Comparative Study of Dementia with Lewy Bodies and Alzheimer Disease. , 2016, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[4]  Toshiki Uchihara,et al.  Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies , 2015, Acta Neuropathologica.

[5]  J. Filoteo,et al.  Recognition memory span in autopsy-confirmed Dementia with Lewy Bodies and Alzheimer's Disease , 2015, Neuropsychologia.

[6]  D. Mann,et al.  Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology , 2015, Neurobiology of Disease.

[7]  N. Cairns,et al.  Comparative quantitative study of ‘signature’ pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders , 2015, Journal of Neural Transmission.

[8]  R. Wade-Martins,et al.  Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain , 2015, Brain : a journal of neurology.

[9]  Fraser T. Sparks,et al.  Hippocampal CA2 Activity Patterns Change over Time to a Larger Extent than between Spatial Contexts , 2015, Neuron.

[10]  E. L. Stevenson,et al.  Lesions to the CA2 region of the hippocampus impair social memory in mice , 2014, The European journal of neuroscience.

[11]  Janna H. Neltner,et al.  Primary age-related tauopathy (PART): a common pathology associated with human aging , 2014, Acta Neuropathologica.

[12]  Chris Bye,et al.  Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. , 2014, Brain : a journal of neurology.

[13]  Masaki Tanaka,et al.  Differential Expression of Alpha-Synuclein in Hippocampal Neurons , 2014, PloS one.

[14]  S. Siegelbaum,et al.  The hippocampal CA2 region is essential for social memory , 2014, Nature.

[15]  Thomas J McHugh,et al.  The Hippocampal CA2 Ensemble Is Sensitive to Contextual Change , 2014, The Journal of Neuroscience.

[16]  N. Cairns,et al.  A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease , 2014, Journal of Neural Transmission.

[17]  Ian R. Wickersham,et al.  Cell type–specific genetic and optogenetic tools reveal hippocampal CA2 circuits , 2013 .

[18]  Menno P. Witter,et al.  Transgenically Targeted Rabies Virus Demonstrates a Major Monosynaptic Projection from Hippocampal Area CA2 to Medial Entorhinal Layer II Neurons , 2013, The Journal of Neuroscience.

[19]  Bin Zhang,et al.  Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons , 2013, Cell.

[20]  C. Gerfen,et al.  Hypothalamic and other connections with dorsal CA2 area of the mouse hippocampus , 2013, The Journal of comparative neurology.

[21]  Daniela Boassa,et al.  Mapping the Subcellular Distribution of α-Synuclein in Neurons using Genetically Encoded Probes for Correlated Light and Electron Microscopy: Implications for Parkinson's Disease Pathogenesis , 2013, The Journal of Neuroscience.

[22]  J. Trojanowski,et al.  Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.

[23]  Allan R. Jones,et al.  An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.

[24]  S. Dudek,et al.  New insights into the regulation of synaptic plasticity from an unexpected place: hippocampal area CA2. , 2012, Learning & memory.

[25]  T. Uchihara,et al.  Pale Neurites, Premature α‐Synuclein Aggregates with Centripetal Extension from Axon Collaterals , 2012, Brain pathology.

[26]  Fiona E. N. LeBeau,et al.  Partial loss of parvalbumin‐containing hippocampal interneurons in dementia with Lewy bodies , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.

[27]  Charles Duyckaerts,et al.  National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.

[28]  Emma R. Wood,et al.  The role of hippocampal subregions in memory for stimulus associations , 2010, Behavioural Brain Research.

[29]  W. Schulz-Schaeffer.  The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia , 2010, Acta Neuropathologica.

[30]  E. Masliah,et al.  A Pathologic Cascade Leading to Synaptic Dysfunction in α-Synuclein-Induced Neurodegeneration , 2010, The Journal of Neuroscience.

[31]  S. Siegelbaum,et al.  Strong CA2 Pyramidal Neuron Synapses Define a Powerful Disynaptic Cortico-Hippocampal Loop , 2010, Neuron.

[32]  G. V. Van Hoesen,et al.  Stratum radiatum of CA2 is an additional target of the perforant path in humans and monkeys , 2010, Neuroreport.

[33]  Howard Eichenbaum,et al.  Vasopressin 1b Receptor Knock-Out Impairs Memory for Temporal Order , 2009, The Journal of Neuroscience.

[34]  J. H. Kim,et al.  Ischemic Evidence of Transient Global Amnesia: Location of the Lesion in the Hippocampus , 2008, Journal of clinical neurology.

[35]  M. Onofrj,et al.  Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium , 2006, Neurology.

[36]  D. Dickson,et al.  Dementia with Lewy bodies and Parkinson's disease with dementia: are they different? , 2005, Parkinsonism & related disorders.

[37]  E. Callaway,et al.  Redefining the boundaries of the hippocampal CA2 subfield in the mouse using gene expression and 3‐dimensional reconstruction , 2005, The Journal of comparative neurology.

[38]  I. Alafuzoff,et al.  α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005, Annals of neurology.

[39]  D. Delis,et al.  A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease , 2004, Journal of the International Neuropsychological Society.

[40]  E. Lein,et al.  Defining a Molecular Atlas of the Hippocampus Using DNA Microarrays and High-Throughput In Situ Hybridization , 2004, The Journal of Neuroscience.

[41]  J. Trojanowski,et al.  Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease , 1994, Acta Neuropathologica.

[42]  E. Lewandowska,et al.  Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia. , 2004, Folia neuropathologica.

[43]  E. Masliah,et al.  Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32 , 2004, Acta Neuropathologica.

[44]  K. Kosaka,et al.  Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson's disease with dementia , 2003, Journal of the Neurological Sciences.

[45]  A. Lees,et al.  Lewy body cortical involvement may not always predict dementia in Parkinson’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[46]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[47]  K. Kosaka,et al.  Relationship in the formation process between neurofibrillary tangles and Lewy bodies in the hippocampus of dementia with Lewy bodies brains , 2002, Journal of the Neurological Sciences.

[48]  Glenda M. Halliday,et al.  Cortical Lewy body pathology in the diagnosis of dementia , 2001, Acta Neuropathologica.

[49]  J. Hodges,et al.  Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[50]  C. Pieper,et al.  Comparison of Lewy body variant of Alzheimer’s disease with pure Alzheimer’s disease , 1999, Neurology.

[51]  E. Mori,et al.  Cognitive loss in dementia with Lewy bodies and Alzheimer disease. , 1998, Archives of neurology.

[52]  L A Hansen,et al.  Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease. , 1998, Archives of neurology.

[53]  A. Lees,et al.  The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease , 1997, Neurology.

[54]  Z Walker,et al.  Neuropsychological performance in Lewy body dementia and Alzheimer's disease , 1997, British Journal of Psychiatry.

[55]  Douglas Galasko,et al.  Neuropsychological Deficits Associated with Diffuse Lewy Body Disease , 1996, Brain and Cognition.

[56]  C. Ballard,et al.  Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type. , 1996, Age and ageing.

[57]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[58]  E. Masliah,et al.  Plaque‐Only Alzheimer Disease is Usually the Lewy Body Variant, and Vice Versa , 1993, Journal of neuropathology and experimental neurology.

[59]  M. Witter,et al.  Morphological and functional correlates of borders in the entorhinal cortex and hippocampus , 1993, Hippocampus.

[60]  L. Squire.  Declarative and Nondeclarative Memory: Multiple Brain Systems Supporting Learning and Memory , 1992, Journal of Cognitive Neuroscience.

[61]  D. Amaral,et al.  Entorhinal cortex of the monkey: V. Projections to the dentate gyrus, hippocampus, and subicular complex , 1991, The Journal of comparative neurology.

[62]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[63]  D. Delis,et al.  The California verbal learning test , 2016 .

[64]  L. Squire,et al.  Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[65]  A. Nappi,et al.  Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .